KLF6 and cancer: Recent studies have reported that KLF6 could serve as a new molecular marker candidate for tumor prognosis and a potential therapeutic target, because abnormal KLF6 expression was associated with a poor clinical prognosis, cancer recurrence, and drug resistance31–34.